We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


REMP’s Repository for Biological Samples Passed Final Site Acceptance Test at Pfizer

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "REMP’s Repository for Biological Samples Passed Final Site Acceptance Test at Pfizer"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

REMP, a Tecan Group company has announced that the REMP repository for biological samples passed the final Site Acceptance Test at Pfizer’s facility in Groton, CT.

The REMP Bio-Sample Store is the automated storage and retrieval system of its size to hold samples at –80°C in combination with the REMP Tube Technology™.

This system is based on reliable sample storage concepts and is fully compatible with all other REMP products and consumables.

The REMP Bio-Sample Store can be used for a wide range of research applications; such as, genomics, proteomics, tissue banking, glycerol stocks and long-term storage of enzymes and other stock solutions.

Additionally, there is the option to store samples at both –80°C and –20°C, within the same storage system, which allows for optimal storage conditions of temperature sensitive molecules such as DNA or antibodies.

This storage system for biological materials was developed jointly with Pfizer Global Research and Development, the R&D arm of Pfizer, Inc. and is able to store millions of samples, concurrently, at –80°C and –20°C under controlled dry air conditions to prevent frost build up.